NASDAQ OMX

Alipay brings enhanced "cashless" experience for Chinese tourists in the Principality of Monaco

Dela
  • Alipay and Government of Monaco signed MoU to promote mobile payment across the state
  • Hotels, restaurants, spas, luxury stores and souvenir shops already onboarded on the Alipay platform

LONDON, June 27, 2017 (GLOBE NEWSWIRE) -- Alipay, the world's largest online and mobile payment platform operated by Ant Financial Services Group ("Ant Financial", "Ant"), today announced that it has signed a MoU with the Government of Monaco, which will enable merchants in Monaco to accept payment via Alipay, giving Chinese tourists the same convenient payment experience that they enjoy at home.

Douglas Feagin, President of International Business, Ant Financial Services Group, said, "As part of our globalization strategy, we are focused on working with local partners to bring a seamless Alipay mobile payment experience to Chinese tourists, no matter where they go. The MoU makes Monaco the 12th country in Europe to accept Alipay, and we are very excited to launch the platform in the principality in collaboration with the Government of Monaco and our banking partner BNP Paribas."

H.E Mr Serge Telle, the Prime Minister of Principality of Monaco, said, "The future is becoming cashless, and China is increasingly leading the market in mobile payment innovations. It is exciting that these frictionless payment methods are available to our Chinese visitors for the first time and we look forward to seeing this partnership come to fruition."

The MoU was agreed at a signing ceremony attended by senior dignitaries and business figures:

  • Douglas Feagin, President of International Business, Ant Financial Services Group
  • H.E Mr Serge Telle, the Prime Minister of Principality of Monaco
  • Bernard D'Alessandri, CEO, Monaco Yacht Club
  • Gilbert Schweitzer, CEO, Monacair
  • Jean Luc Biamonti, CEO, Monte-Carlo Société des Bains de Mer
  • Didier Boidin, COO, Monte-Carlo Société des Bains de Mer
  • Serge Ethuin CEO, Métropole Hotel
  • Xavier Rugeroni, General Manager and Régional Vice President, Fairmont Hotel, Monte Carlo

Over ten merchants in Monaco are already accepting Alipay, including Monte-Carlo Société des Bains de Mer with 4 hotels (Hôtel de Paris Monte-Carlo, Hotel Hermitage Monte-Carlo, Monte-Carlo Bay Hotel and Resort, Monte-Carlo Beach), 3 spas including Thermes Marins Monte-Carlo, souvenir and gifts shops, and restaurants and bars. Alipay is also accepted by Monacair, Monaco's V.I.P. helicopter airline and official supplier to S.A.S. the Sovereign Prince of Monaco. Merchants who may onboard with the platform in the coming months include the Monaco Yacht Club, Metropole Hotel, and the Fairmont Hotel.

BNP Paribas, one of Alipay's key partners in Europe, enables merchants to accept Alipay across Monaco.

The agreement was brokered by Stelitt, which has partnered with Ant Financial in marketing Alipay in Monaco and France.

Pascal Do, CEO of Stelitt added: "Tourism accounts for 12% - 15% of GDP in Monaco and is a major driver of the economy. We are happy to connect Monaco and Alipay; making it easier for Chinese visitors to purchase souvenirs and experiences in a cashless way is a win-win."

Alipay is now accepted by more than eight million merchants across China and 120 thousand bricks-and-mortar shops overseas. Ant Financial has a number of key collaborations in Europe through its network of local acquirers including BNP Paribas, Barclays, Concardis, Ingenico, SIX, UniCredit, SIX, and Wirecard.

About Alipay
Operated by Ant Financial Services Group, Alipay is the world's leading mobile and online payment platform. Launched in 2004, Alipay currently has over 450 million active users and over 400 financial institution partners. Alipay has evolved from a digital wallet to a lifestyle enabler. Users can hail a taxi, book a hotel, buy movie tickets, pay utility bills, make appointments with doctors, or purchase wealth management products directly from within the app. In addition to online payments, Alipay is expanding to in-store offline payments both inside and outside of China. Over 8 million brick-and-mortar merchants now accept Alipay across China. Alipay's in-store payment service is covering more than 120,000 retail stores across the world, and tax reimbursement via Alipay is supported in 24 countries and regions. Alipay works with over 200 overseas financial institutions and payment solution providers to enable cross-border payments for Chinese travelling overseas and overseas customers who purchase products from Chinese e-commerce sites. Alipay currently supports 19 currencies. 

About Ant Financial
Ant Financial Services Group is focused on serving small and micro enterprises, as well as individuals. With the vision "bring the world equal opportunities," Ant Financial is dedicated to building an open ecosystem of Internet thinking and technologies while working with other financial institutions to support the future financial needs of society. Businesses operated by Ant Financial Services Group include Alipay, Ant Fortune, Zhima Credit and MYbank.

For more information on Ant Financial, please visit our website at www.antgroup.com; or follow us on Twitter @AntFinancial.

Media Enquiries
Ant Financial
Xinyun Yang
xinyun.yang@antfin.com
+86 138 1689 6301



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ant Financial Services Group via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Karolinska Development's portfolio company Asarina Pharma is listed on Nasdaq First North24.9.2018 08:00Pressmeddelande

STOCKHOLM, 24 September 2018. Karolinska Development's portfolio company Asarina Pharma will today be listed on Nasdaq First North in Stockholm. In connection with the listing, Asarina Pharma is issuing 6.8 million shares. The issue price of SEK 21 gives Asarina Pharma a pre money valuation of SEK 172 million. Conditioned that the over-allotment option of an additional 0.35 million shares is fully exercised, Asarina Pharma will be provided with a total of SEK 150.2 million before issue costs. Asarina Pharma is a Swedish biotech company focused on chronic diseases associated with the menstrual cycle. The portfolio company is developing the drug candidate sepranolone as a treatment for premenstrual dysphoric disorder (PMDD) and premenstrual migraine. A Phase IIb study is currently underway in PMDD with expected completion by the end of 2019. Furthermore, Asarina Pharma is planning a clinical Phase IIa study in menstrual migraine for the first half of 2019. Karolinska Development is a pas

Karolinska Development's portfolio company Asarina Pharma is listed on Nasdaq First North24.9.2018 08:00Pressmeddelande

STOCKHOLM, 24 September 2018. Karolinska Development's portfolio company Asarina Pharma will today be listed on Nasdaq First North in Stockholm. In connection with the listing, Asarina Pharma is issuing 6.8 million shares. The issue price of SEK 21 gives Asarina Pharma a pre money valuation of SEK 172 million. Conditioned that the over-allotment option of an additional 0.35 million shares is fully exercised, Asarina Pharma will be provided with a total of SEK 150.2 million before issue costs. Asarina Pharma is a Swedish biotech company focused on chronic diseases associated with the menstrual cycle. The portfolio company is developing the drug candidate sepranolone as a treatment for premenstrual dysphoric disorder (PMDD) and premenstrual migraine. A Phase IIb study is currently underway in PMDD with expected completion by the end of 2019. Furthermore, Asarina Pharma is planning a clinical Phase IIa study in menstrual migraine for the first half of 2019. Karolinska Development is a pas

Immunicum AB (publ) meddelar att Pawel Kalinski och Inge Marie Svane har valts in i det vetenskapliga rådet17.9.2018 08:00Pressmeddelande

Pressmeddelande 17 september 2018 Immunicum AB (publ) meddelar att Pawel Kalinski och Inge Marie Svane har valts in i det vetenskapliga rådet Immunicum AB (publ; IMMU.ST) meddelade i dag att två ledande immun-onkologiska experter har valts in i bolagets vetenskapliga råd för att fungera som strategiska resurser för Immunicum under bolagets fortsatta kliniska utveckling av sin ledande produkt, ilixadencel. Pawel Kalinski, MD, PhD, vice ordförande för translationell forskning vid den medicinska institutionen vid Roswell Park Comprehensive Cancer Center, och Inge Marie Svane, MD, PhD, professor, chef för det kliniska cancerforskningsprogrammet på medicinska fakulteten vid Köpenhamns universitet, chef för Center för cancerimmunterapi (CCIT) samt överläkare inom onkologi, Herlevs universitetssjukhus har valts in i rådet. - Vi är hedrade att ha experter med specialistkompetens inom området immunonkologi och cellterapi i vårt vetenskapliga råd, vilka kan erbjuda ytterligare vägledning när det

Immunicum AB (publ) Announces Appointment of Pawel Kalinski and Inge Marie Svane to Scientific Advisory Board17.9.2018 08:00Pressmeddelande

Press Release 17 September 2018 Immunicum AB (publ) Announces Appointment of Pawel Kalinski and Inge Marie Svane to Scientific Advisory Board Immunicum AB (publ; IMMU.ST) announced today the appointment of leading oncology experts to its Scientific Advisory Board with the addition of Pawel Kalinski, MD, PhD, Vice Chair for Translational Research within the Department of Medicine at Roswell Park Comprehensive Cancer Center, and Inge Marie Svane, MD, PhD, Professor, Head of the Clinical Cancer Research programme, Faculty of Health Sciences, University of Copenhagen, Director, Centre for Cancer Immunotherapy (CCIT), and consultant in Oncology, Herlev University Hospital. Both Scientific Advisory Board members will serve as a strategic resource to Immunicum as the company continues to advance the clinical development of its lead product, ilixadencel. "We are honored to have such highly specialized experts in the field of immuno-oncology and cell therapy join our Scientific Advisory Board a

Hoylu AB: HOYLU HIRES NEW CTO, SATOSHI NAKAJIMA AND ANNOUNCES EXPANSION INTO JAPAN14.9.2018 08:30Pressmeddelande

Malmo, Sweden, September 14, 2018 - Hoylu, a leading enterprise collaboration company, announced today Satoshi Nakajima will join Hoylu in the newly created position, as Chief Technology Officer and President of Hoylu Japan. Nakajima will guide the strategic technology direction and innovation of Hoylu while also leading the new Hoylu office in Tokyo, Japan. "Satoshi is a visionary and world-class technologist who has substantial experience in delivering world class innovations. He is joining the Company as we are extending our reach and expanding into Japan," said Stein Revelsby, CEO. "Satoshi's extensive experience in strategy and delivering technology that support a great user experience will make an immediate impact on the company." Nakajima will serve as President of Hoylu Japan and will report to Stein Revelsby. His leadership will strengthen customer relations and help develop new business among emerging and established Japanese companies while strengthening the global position

Hoylu AB: HOYLU ANSTÄLLER SATOSHI NAKAJIMA SOM NY CTO OCH EXPANDERAR TILL JAPAN14.9.2018 08:30Pressmeddelande

Malmö, Sverige, 14 september 2018 - Hoylu, ett ledande företag inom samarbetsmjukvara för företagsmarknaden annonserar idag att Satoshi Nakajima tar anställning som CTO (Chief Technology Officer) och President för Hoylu Japan. Nakajima kommer styra den strategiska inriktningen för företagets produkter och leda innovationsarbetet. Han kommer också leda Hoylus nyöppnade kontor i Tokyo, Japan. Satoshi är en visionär teknologiexpert som har stor erfarenhet av att skapa innovativa lösningar. Han kommer till Hoylu samtidigt som vi utökar marknaden till att även täcka in Japan säger Stein Revelsby, VD. "Satoshis långa och gedigna erfarenhet i strategiska frågor och tekniska lösningar med fokus på användarupplevelse kommer få stor betydelse för oss." Nakajima kommer även att bli President för Hoylu Japan och kommer rapportera till Stein Revelsby. Hans ledarskap kommer stärka existerande kundrelationer och utveckla nya affärer på den japanska marknaden och samtidigt bidra till att flytta fram p

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum